nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—ABCC1—hypertension	0.239	0.813	CbGaD
Vemurafenib—ALB—hypertension	0.0549	0.187	CbGaD
Vemurafenib—ORM1—Penbutolol—hypertension	0.0276	0.064	CbGbCtD
Vemurafenib—ORM1—Doxazosin—hypertension	0.0266	0.0616	CbGbCtD
Vemurafenib—ORM1—Prazosin—hypertension	0.0218	0.0506	CbGbCtD
Vemurafenib—ORM1—Propranolol—hypertension	0.0173	0.0402	CbGbCtD
Vemurafenib—ALB—Ethacrynic acid—hypertension	0.0153	0.0355	CbGbCtD
Vemurafenib—ABCG2—Telmisartan—hypertension	0.0147	0.0341	CbGbCtD
Vemurafenib—ABCC1—Atorvastatin—hypertension	0.0134	0.0311	CbGbCtD
Vemurafenib—ABCG2—Prazosin—hypertension	0.0133	0.0309	CbGbCtD
Vemurafenib—ABCC1—Verapamil—hypertension	0.0108	0.0251	CbGbCtD
Vemurafenib—ALB—Valsartan—hypertension	0.00987	0.0229	CbGbCtD
Vemurafenib—CYP1A2—Triamterene—hypertension	0.00916	0.0212	CbGbCtD
Vemurafenib—CYP1A2—Guanabenz—hypertension	0.00916	0.0212	CbGbCtD
Vemurafenib—CYP2D6—Labetalol—hypertension	0.00826	0.0191	CbGbCtD
Vemurafenib—CYP2D6—Nebivolol—hypertension	0.00826	0.0191	CbGbCtD
Vemurafenib—CYP1A2—Betaxolol—hypertension	0.00759	0.0176	CbGbCtD
Vemurafenib—CYP2D6—Acebutolol—hypertension	0.00755	0.0175	CbGbCtD
Vemurafenib—ABCG2—Verapamil—hypertension	0.00726	0.0168	CbGbCtD
Vemurafenib—ALB—Captopril—hypertension	0.0072	0.0167	CbGbCtD
Vemurafenib—CYP2D6—Metoprolol—hypertension	0.00702	0.0163	CbGbCtD
Vemurafenib—CYP2D6—Pindolol—hypertension	0.00702	0.0163	CbGbCtD
Vemurafenib—CYP3A4—Guanethidine—hypertension	0.00693	0.0161	CbGbCtD
Vemurafenib—CYP1A2—Nisoldipine—hypertension	0.00669	0.0155	CbGbCtD
Vemurafenib—CYP2D6—Betaxolol—hypertension	0.00626	0.0145	CbGbCtD
Vemurafenib—ALB—Furosemide—hypertension	0.00579	0.0134	CbGbCtD
Vemurafenib—ALB—Losartan—hypertension	0.00567	0.0131	CbGbCtD
Vemurafenib—CYP2D6—Doxazosin—hypertension	0.00551	0.0128	CbGbCtD
Vemurafenib—CYP2D6—Diltiazem—hypertension	0.00532	0.0123	CbGbCtD
Vemurafenib—CYP1A2—Irbesartan—hypertension	0.00526	0.0122	CbGbCtD
Vemurafenib—CYP3A4—Hydralazine—hypertension	0.00525	0.0122	CbGbCtD
Vemurafenib—CYP1A2—Amlodipine—hypertension	0.00516	0.012	CbGbCtD
Vemurafenib—CYP1A2—Nifedipine—hypertension	0.00481	0.0112	CbGbCtD
Vemurafenib—CYP2D6—Bepridil—hypertension	0.00474	0.011	CbGbCtD
Vemurafenib—CYP1A2—Carvedilol—hypertension	0.00474	0.011	CbGbCtD
Vemurafenib—CYP3A4—Guanfacine—hypertension	0.00446	0.0103	CbGbCtD
Vemurafenib—CYP1A2—Propranolol—hypertension	0.00436	0.0101	CbGbCtD
Vemurafenib—CYP2D6—Irbesartan—hypertension	0.00434	0.0101	CbGbCtD
Vemurafenib—CYP2D6—Amlodipine—hypertension	0.00425	0.00986	CbGbCtD
Vemurafenib—CYP1A2—Clonidine—hypertension	0.00416	0.00964	CbGbCtD
Vemurafenib—CYP2D6—Felodipine—hypertension	0.0041	0.0095	CbGbCtD
Vemurafenib—CYP2D6—Timolol—hypertension	0.00403	0.00934	CbGbCtD
Vemurafenib—CYP3A4—Isradipine—hypertension	0.00398	0.00922	CbGbCtD
Vemurafenib—CYP2D6—Nifedipine—hypertension	0.00397	0.00919	CbGbCtD
Vemurafenib—CYP2D6—Nicardipine—hypertension	0.0039	0.00905	CbGbCtD
Vemurafenib—CYP2D6—Carvedilol—hypertension	0.0039	0.00905	CbGbCtD
Vemurafenib—CYP2D6—Propranolol—hypertension	0.00359	0.00833	CbGbCtD
Vemurafenib—CYP2D6—Captopril—hypertension	0.00355	0.00823	CbGbCtD
Vemurafenib—CYP3A4—Nisoldipine—hypertension	0.0035	0.00812	CbGbCtD
Vemurafenib—CYP3A4—Indapamide—hypertension	0.0035	0.00812	CbGbCtD
Vemurafenib—CYP2D6—Clonidine—hypertension	0.00343	0.00795	CbGbCtD
Vemurafenib—CYP1A2—Losartan—hypertension	0.00339	0.00786	CbGbCtD
Vemurafenib—CYP3A4—Diltiazem—hypertension	0.00338	0.00784	CbGbCtD
Vemurafenib—CYP3A4—Eplerenone—hypertension	0.00338	0.00784	CbGbCtD
Vemurafenib—CYP2D6—Atorvastatin—hypertension	0.00306	0.00708	CbGbCtD
Vemurafenib—CYP3A4—Enalapril—hypertension	0.00301	0.00699	CbGbCtD
Vemurafenib—CYP1A2—Verapamil—hypertension	0.00299	0.00694	CbGbCtD
Vemurafenib—CYP3A4—Irbesartan—hypertension	0.00276	0.00639	CbGbCtD
Vemurafenib—CYP3A4—Amlodipine—hypertension	0.0027	0.00627	CbGbCtD
Vemurafenib—CYP3A4—Felodipine—hypertension	0.00261	0.00604	CbGbCtD
Vemurafenib—CYP3A4—Nifedipine—hypertension	0.00252	0.00585	CbGbCtD
Vemurafenib—CYP3A4—Carvedilol—hypertension	0.00248	0.00575	CbGbCtD
Vemurafenib—CYP3A4—Nicardipine—hypertension	0.00248	0.00575	CbGbCtD
Vemurafenib—CYP2D6—Verapamil—hypertension	0.00247	0.00572	CbGbCtD
Vemurafenib—CYP3A4—Propranolol—hypertension	0.00228	0.0053	CbGbCtD
Vemurafenib—CYP3A4—Clonidine—hypertension	0.00218	0.00505	CbGbCtD
Vemurafenib—CYP3A4—Atorvastatin—hypertension	0.00194	0.0045	CbGbCtD
Vemurafenib—CYP3A4—Losartan—hypertension	0.00178	0.00412	CbGbCtD
Vemurafenib—CYP3A4—Verapamil—hypertension	0.00157	0.00363	CbGbCtD
Vemurafenib—CYP1A2—urine—hypertension	0.000963	0.0494	CbGeAlD
Vemurafenib—RAF1—cardiac ventricle—hypertension	0.000944	0.0484	CbGeAlD
Vemurafenib—BRAF—heart—hypertension	0.00093	0.0477	CbGeAlD
Vemurafenib—RAF1—myocardium—hypertension	0.000888	0.0455	CbGeAlD
Vemurafenib—RAF1—brainstem—hypertension	0.000717	0.0367	CbGeAlD
Vemurafenib—CYP3A4—urine—hypertension	0.000697	0.0357	CbGeAlD
Vemurafenib—BRAF—adrenal gland—hypertension	0.000694	0.0356	CbGeAlD
Vemurafenib—CYP2D6—urine—hypertension	0.000686	0.0352	CbGeAlD
Vemurafenib—RAF1—nephron tubule—hypertension	0.000651	0.0334	CbGeAlD
Vemurafenib—RAF1—adrenal cortex—hypertension	0.000641	0.0328	CbGeAlD
Vemurafenib—RAF1—heart—hypertension	0.00062	0.0318	CbGeAlD
Vemurafenib—RAF1—smooth muscle tissue—hypertension	0.000615	0.0315	CbGeAlD
Vemurafenib—RAF1—decidua—hypertension	0.000603	0.0309	CbGeAlD
Vemurafenib—RAF1—cardiovascular system—hypertension	0.000585	0.03	CbGeAlD
Vemurafenib—RAF1—kidney—hypertension	0.000572	0.0293	CbGeAlD
Vemurafenib—RAF1—cortex of kidney—hypertension	0.000557	0.0286	CbGeAlD
Vemurafenib—RAF1—cardiac atrium—hypertension	0.00053	0.0272	CbGeAlD
Vemurafenib—RAF1—medulla oblongata—hypertension	0.0005	0.0256	CbGeAlD
Vemurafenib—RAF1—adrenal gland—hypertension	0.000463	0.0237	CbGeAlD
Vemurafenib—ABCC1—myocardium—hypertension	0.000444	0.0227	CbGeAlD
Vemurafenib—RAF1—endocrine gland—hypertension	0.000401	0.0206	CbGeAlD
Vemurafenib—ALB—heart—hypertension	0.000375	0.0192	CbGeAlD
Vemurafenib—RAF1—central nervous system—hypertension	0.000362	0.0185	CbGeAlD
Vemurafenib—ABCC1—adrenal cortex—hypertension	0.00032	0.0164	CbGeAlD
Vemurafenib—ABCC1—heart—hypertension	0.00031	0.0159	CbGeAlD
Vemurafenib—ABCC1—decidua—hypertension	0.000301	0.0154	CbGeAlD
Vemurafenib—ALB—adrenal gland—hypertension	0.00028	0.0144	CbGeAlD
Vemurafenib—ABCC1—cortex of kidney—hypertension	0.000278	0.0143	CbGeAlD
Vemurafenib—ORM1—endocrine gland—hypertension	0.000277	0.0142	CbGeAlD
Vemurafenib—ABCG2—nephron tubule—hypertension	0.000269	0.0138	CbGeAlD
Vemurafenib—ABCG2—adrenal cortex—hypertension	0.000265	0.0136	CbGeAlD
Vemurafenib—ABCC1—cardiac atrium—hypertension	0.000265	0.0136	CbGeAlD
Vemurafenib—ABCG2—heart—hypertension	0.000256	0.0131	CbGeAlD
Vemurafenib—ORM1—central nervous system—hypertension	0.00025	0.0128	CbGeAlD
Vemurafenib—ABCG2—decidua—hypertension	0.000249	0.0128	CbGeAlD
Vemurafenib—ABCC1—adrenal gland—hypertension	0.000231	0.0118	CbGeAlD
Vemurafenib—ABCG2—medulla oblongata—hypertension	0.000207	0.0106	CbGeAlD
Vemurafenib—CYP2D6—brainstem—hypertension	0.000203	0.0104	CbGeAlD
Vemurafenib—ABCG2—adrenal gland—hypertension	0.000191	0.00981	CbGeAlD
Vemurafenib—CYP3A4—kidney—hypertension	0.000165	0.00845	CbGeAlD
Vemurafenib—Etoricoxib—PTGS2—hypertension	0.000163	1	CrCbGaD
Vemurafenib—CYP2D6—kidney—hypertension	0.000162	0.00832	CbGeAlD
Vemurafenib—CYP1A2—endocrine gland—hypertension	0.00016	0.00819	CbGeAlD
Vemurafenib—CYP3A4—endocrine gland—hypertension	0.000116	0.00592	CbGeAlD
Vemurafenib—CYP2D6—endocrine gland—hypertension	0.000114	0.00583	CbGeAlD
Vemurafenib—CYP3A4—central nervous system—hypertension	0.000104	0.00534	CbGeAlD
Vemurafenib—CYP2D6—central nervous system—hypertension	0.000103	0.00525	CbGeAlD
Vemurafenib—Vomiting—Indapamide—hypertension	4.25e-05	0.000293	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Ramipril—hypertension	4.25e-05	0.000293	CcSEcCtD
Vemurafenib—Asthenia—Valsartan—hypertension	4.24e-05	0.000293	CcSEcCtD
Vemurafenib—Constipation—Furosemide—hypertension	4.24e-05	0.000292	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Betaxolol—hypertension	4.24e-05	0.000292	CcSEcCtD
Vemurafenib—Fatigue—Betaxolol—hypertension	4.23e-05	0.000292	CcSEcCtD
Vemurafenib—Asthenia—Olmesartan—hypertension	4.22e-05	0.000291	CcSEcCtD
Vemurafenib—Dizziness—Nifedipine—hypertension	4.22e-05	0.000291	CcSEcCtD
Vemurafenib—Rash—Indapamide—hypertension	4.21e-05	0.000291	CcSEcCtD
Vemurafenib—Rash—Diltiazem—hypertension	4.21e-05	0.000291	CcSEcCtD
Vemurafenib—Dermatitis—Indapamide—hypertension	4.21e-05	0.00029	CcSEcCtD
Vemurafenib—Dermatitis—Diltiazem—hypertension	4.21e-05	0.00029	CcSEcCtD
Vemurafenib—Vomiting—Carvedilol—hypertension	4.21e-05	0.00029	CcSEcCtD
Vemurafenib—Dizziness—Verapamil—hypertension	4.2e-05	0.00029	CcSEcCtD
Vemurafenib—Constipation—Betaxolol—hypertension	4.2e-05	0.000289	CcSEcCtD
Vemurafenib—Headache—Diltiazem—hypertension	4.19e-05	0.000289	CcSEcCtD
Vemurafenib—Headache—Indapamide—hypertension	4.19e-05	0.000289	CcSEcCtD
Vemurafenib—Pruritus—Valsartan—hypertension	4.18e-05	0.000289	CcSEcCtD
Vemurafenib—Myalgia—Timolol—hypertension	4.18e-05	0.000288	CcSEcCtD
Vemurafenib—Arthralgia—Timolol—hypertension	4.18e-05	0.000288	CcSEcCtD
Vemurafenib—Rash—Carvedilol—hypertension	4.17e-05	0.000288	CcSEcCtD
Vemurafenib—Dermatitis—Carvedilol—hypertension	4.17e-05	0.000288	CcSEcCtD
Vemurafenib—Pruritus—Olmesartan—hypertension	4.16e-05	0.000287	CcSEcCtD
Vemurafenib—Vomiting—Doxazosin—hypertension	4.16e-05	0.000287	CcSEcCtD
Vemurafenib—Decreased appetite—Losartan—hypertension	4.16e-05	0.000287	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Timolol—hypertension	4.15e-05	0.000287	CcSEcCtD
Vemurafenib—Hypersensitivity—Clonidine—hypertension	4.15e-05	0.000286	CcSEcCtD
Vemurafenib—Body temperature increased—Captopril—hypertension	4.15e-05	0.000286	CcSEcCtD
Vemurafenib—Headache—Carvedilol—hypertension	4.15e-05	0.000286	CcSEcCtD
Vemurafenib—Rash—Doxazosin—hypertension	4.13e-05	0.000285	CcSEcCtD
Vemurafenib—Fatigue—Losartan—hypertension	4.12e-05	0.000284	CcSEcCtD
Vemurafenib—Dermatitis—Doxazosin—hypertension	4.12e-05	0.000284	CcSEcCtD
Vemurafenib—Vomiting—Fosinopril—hypertension	4.11e-05	0.000284	CcSEcCtD
Vemurafenib—Nausea—Propranolol—hypertension	4.1e-05	0.000283	CcSEcCtD
Vemurafenib—Anaphylactic shock—Ramipril—hypertension	4.1e-05	0.000283	CcSEcCtD
Vemurafenib—Headache—Doxazosin—hypertension	4.1e-05	0.000283	CcSEcCtD
Vemurafenib—Constipation—Losartan—hypertension	4.09e-05	0.000282	CcSEcCtD
Vemurafenib—Vomiting—Eplerenone—hypertension	4.09e-05	0.000282	CcSEcCtD
Vemurafenib—Rash—Fosinopril—hypertension	4.08e-05	0.000281	CcSEcCtD
Vemurafenib—Dermatitis—Fosinopril—hypertension	4.07e-05	0.000281	CcSEcCtD
Vemurafenib—Vomiting—Nifedipine—hypertension	4.06e-05	0.00028	CcSEcCtD
Vemurafenib—Rash—Eplerenone—hypertension	4.05e-05	0.00028	CcSEcCtD
Vemurafenib—Headache—Fosinopril—hypertension	4.05e-05	0.000279	CcSEcCtD
Vemurafenib—Hypersensitivity—Trandolapril—hypertension	4.05e-05	0.000279	CcSEcCtD
Vemurafenib—Dermatitis—Eplerenone—hypertension	4.05e-05	0.000279	CcSEcCtD
Vemurafenib—Diarrhoea—Valsartan—hypertension	4.05e-05	0.000279	CcSEcCtD
Vemurafenib—Asthenia—Clonidine—hypertension	4.04e-05	0.000279	CcSEcCtD
Vemurafenib—Vomiting—Verapamil—hypertension	4.04e-05	0.000279	CcSEcCtD
Vemurafenib—Hypersensitivity—Enalapril—hypertension	4.03e-05	0.000278	CcSEcCtD
Vemurafenib—Body temperature increased—Perindopril—hypertension	4.03e-05	0.000278	CcSEcCtD
Vemurafenib—Diarrhoea—Olmesartan—hypertension	4.03e-05	0.000278	CcSEcCtD
Vemurafenib—Headache—Eplerenone—hypertension	4.03e-05	0.000278	CcSEcCtD
Vemurafenib—Rash—Nifedipine—hypertension	4.02e-05	0.000277	CcSEcCtD
Vemurafenib—Nervous system disorder—Ramipril—hypertension	4.02e-05	0.000277	CcSEcCtD
Vemurafenib—Dermatitis—Nifedipine—hypertension	4.02e-05	0.000277	CcSEcCtD
Vemurafenib—Body temperature increased—Irbesartan—hypertension	4.02e-05	0.000277	CcSEcCtD
Vemurafenib—Anaphylactic shock—Timolol—hypertension	4.01e-05	0.000277	CcSEcCtD
Vemurafenib—Rash—Verapamil—hypertension	4.01e-05	0.000276	CcSEcCtD
Vemurafenib—Dermatitis—Verapamil—hypertension	4e-05	0.000276	CcSEcCtD
Vemurafenib—Headache—Nifedipine—hypertension	4e-05	0.000276	CcSEcCtD
Vemurafenib—Pruritus—Clonidine—hypertension	3.99e-05	0.000275	CcSEcCtD
Vemurafenib—Body temperature increased—Hydrochlorothiazide—hypertension	3.98e-05	0.000275	CcSEcCtD
Vemurafenib—Skin disorder—Ramipril—hypertension	3.98e-05	0.000275	CcSEcCtD
Vemurafenib—Infection—Timolol—hypertension	3.98e-05	0.000275	CcSEcCtD
Vemurafenib—Headache—Verapamil—hypertension	3.98e-05	0.000274	CcSEcCtD
Vemurafenib—Hypersensitivity—Telmisartan—hypertension	3.98e-05	0.000274	CcSEcCtD
Vemurafenib—Cough—Lisinopril—hypertension	3.98e-05	0.000274	CcSEcCtD
Vemurafenib—Nausea—Diltiazem—hypertension	3.97e-05	0.000274	CcSEcCtD
Vemurafenib—Nausea—Indapamide—hypertension	3.97e-05	0.000274	CcSEcCtD
Vemurafenib—Asthenia—Trandolapril—hypertension	3.94e-05	0.000272	CcSEcCtD
Vemurafenib—Nervous system disorder—Timolol—hypertension	3.93e-05	0.000271	CcSEcCtD
Vemurafenib—Nausea—Carvedilol—hypertension	3.93e-05	0.000271	CcSEcCtD
Vemurafenib—Asthenia—Enalapril—hypertension	3.93e-05	0.000271	CcSEcCtD
Vemurafenib—Body temperature increased—Furosemide—hypertension	3.92e-05	0.00027	CcSEcCtD
Vemurafenib—Dizziness—Valsartan—hypertension	3.91e-05	0.00027	CcSEcCtD
Vemurafenib—Skin disorder—Timolol—hypertension	3.89e-05	0.000269	CcSEcCtD
Vemurafenib—Dizziness—Olmesartan—hypertension	3.89e-05	0.000268	CcSEcCtD
Vemurafenib—Pruritus—Trandolapril—hypertension	3.89e-05	0.000268	CcSEcCtD
Vemurafenib—Nausea—Doxazosin—hypertension	3.89e-05	0.000268	CcSEcCtD
Vemurafenib—Arthralgia—Lisinopril—hypertension	3.88e-05	0.000268	CcSEcCtD
Vemurafenib—Myalgia—Lisinopril—hypertension	3.88e-05	0.000268	CcSEcCtD
Vemurafenib—Body temperature increased—Betaxolol—hypertension	3.88e-05	0.000268	CcSEcCtD
Vemurafenib—Asthenia—Telmisartan—hypertension	3.88e-05	0.000267	CcSEcCtD
Vemurafenib—Pruritus—Enalapril—hypertension	3.87e-05	0.000267	CcSEcCtD
Vemurafenib—Diarrhoea—Clonidine—hypertension	3.86e-05	0.000266	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	3.85e-05	0.000266	CcSEcCtD
Vemurafenib—Nausea—Fosinopril—hypertension	3.84e-05	0.000265	CcSEcCtD
Vemurafenib—Hypotension—Ramipril—hypertension	3.83e-05	0.000264	CcSEcCtD
Vemurafenib—Pruritus—Telmisartan—hypertension	3.82e-05	0.000264	CcSEcCtD
Vemurafenib—Nausea—Eplerenone—hypertension	3.82e-05	0.000263	CcSEcCtD
Vemurafenib—Nausea—Nifedipine—hypertension	3.79e-05	0.000261	CcSEcCtD
Vemurafenib—Body temperature increased—Losartan—hypertension	3.78e-05	0.000261	CcSEcCtD
Vemurafenib—Nausea—Verapamil—hypertension	3.77e-05	0.00026	CcSEcCtD
Vemurafenib—Asthenia—Captopril—hypertension	3.77e-05	0.00026	CcSEcCtD
Vemurafenib—Diarrhoea—Trandolapril—hypertension	3.76e-05	0.000259	CcSEcCtD
Vemurafenib—Vomiting—Valsartan—hypertension	3.76e-05	0.000259	CcSEcCtD
Vemurafenib—Diarrhoea—Enalapril—hypertension	3.75e-05	0.000258	CcSEcCtD
Vemurafenib—Hypotension—Timolol—hypertension	3.75e-05	0.000258	CcSEcCtD
Vemurafenib—Hypersensitivity—Irbesartan—hypertension	3.74e-05	0.000258	CcSEcCtD
Vemurafenib—Vomiting—Olmesartan—hypertension	3.74e-05	0.000258	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Ramipril—hypertension	3.74e-05	0.000258	CcSEcCtD
Vemurafenib—Rash—Valsartan—hypertension	3.73e-05	0.000257	CcSEcCtD
Vemurafenib—Dizziness—Clonidine—hypertension	3.73e-05	0.000257	CcSEcCtD
Vemurafenib—Dermatitis—Valsartan—hypertension	3.73e-05	0.000257	CcSEcCtD
Vemurafenib—Anaphylactic shock—Lisinopril—hypertension	3.72e-05	0.000257	CcSEcCtD
Vemurafenib—Pruritus—Captopril—hypertension	3.72e-05	0.000256	CcSEcCtD
Vemurafenib—Hypersensitivity—Hydrochlorothiazide—hypertension	3.71e-05	0.000256	CcSEcCtD
Vemurafenib—Rash—Olmesartan—hypertension	3.71e-05	0.000256	CcSEcCtD
Vemurafenib—Dermatitis—Olmesartan—hypertension	3.71e-05	0.000256	CcSEcCtD
Vemurafenib—Headache—Valsartan—hypertension	3.7e-05	0.000256	CcSEcCtD
Vemurafenib—Diarrhoea—Telmisartan—hypertension	3.7e-05	0.000255	CcSEcCtD
Vemurafenib—Infection—Lisinopril—hypertension	3.7e-05	0.000255	CcSEcCtD
Vemurafenib—Headache—Olmesartan—hypertension	3.69e-05	0.000254	CcSEcCtD
Vemurafenib—Asthenia—Perindopril—hypertension	3.66e-05	0.000252	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Timolol—hypertension	3.65e-05	0.000252	CcSEcCtD
Vemurafenib—Hypersensitivity—Furosemide—hypertension	3.65e-05	0.000252	CcSEcCtD
Vemurafenib—Asthenia—Irbesartan—hypertension	3.65e-05	0.000252	CcSEcCtD
Vemurafenib—Dizziness—Trandolapril—hypertension	3.64e-05	0.000251	CcSEcCtD
Vemurafenib—Dizziness—Enalapril—hypertension	3.62e-05	0.00025	CcSEcCtD
Vemurafenib—Asthenia—Hydrochlorothiazide—hypertension	3.62e-05	0.000249	CcSEcCtD
Vemurafenib—Hypersensitivity—Betaxolol—hypertension	3.62e-05	0.000249	CcSEcCtD
Vemurafenib—Skin disorder—Lisinopril—hypertension	3.61e-05	0.000249	CcSEcCtD
Vemurafenib—Pruritus—Perindopril—hypertension	3.61e-05	0.000249	CcSEcCtD
Vemurafenib—Pruritus—Irbesartan—hypertension	3.6e-05	0.000248	CcSEcCtD
Vemurafenib—Diarrhoea—Captopril—hypertension	3.59e-05	0.000248	CcSEcCtD
Vemurafenib—Vomiting—Clonidine—hypertension	3.58e-05	0.000247	CcSEcCtD
Vemurafenib—Dizziness—Telmisartan—hypertension	3.57e-05	0.000246	CcSEcCtD
Vemurafenib—Pruritus—Hydrochlorothiazide—hypertension	3.57e-05	0.000246	CcSEcCtD
Vemurafenib—Decreased appetite—Ramipril—hypertension	3.57e-05	0.000246	CcSEcCtD
Vemurafenib—Asthenia—Furosemide—hypertension	3.56e-05	0.000245	CcSEcCtD
Vemurafenib—Rash—Clonidine—hypertension	3.55e-05	0.000245	CcSEcCtD
Vemurafenib—Dermatitis—Clonidine—hypertension	3.55e-05	0.000245	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Ramipril—hypertension	3.54e-05	0.000244	CcSEcCtD
Vemurafenib—Fatigue—Ramipril—hypertension	3.54e-05	0.000244	CcSEcCtD
Vemurafenib—Headache—Clonidine—hypertension	3.53e-05	0.000244	CcSEcCtD
Vemurafenib—Hypersensitivity—Losartan—hypertension	3.52e-05	0.000243	CcSEcCtD
Vemurafenib—Asthenia—Betaxolol—hypertension	3.52e-05	0.000243	CcSEcCtD
Vemurafenib—Nausea—Valsartan—hypertension	3.51e-05	0.000242	CcSEcCtD
Vemurafenib—Pruritus—Furosemide—hypertension	3.51e-05	0.000242	CcSEcCtD
Vemurafenib—Constipation—Ramipril—hypertension	3.51e-05	0.000242	CcSEcCtD
Vemurafenib—Nausea—Olmesartan—hypertension	3.5e-05	0.000241	CcSEcCtD
Vemurafenib—Vomiting—Trandolapril—hypertension	3.5e-05	0.000241	CcSEcCtD
Vemurafenib—Diarrhoea—Perindopril—hypertension	3.49e-05	0.000241	CcSEcCtD
Vemurafenib—Decreased appetite—Timolol—hypertension	3.49e-05	0.00024	CcSEcCtD
Vemurafenib—Vomiting—Enalapril—hypertension	3.48e-05	0.00024	CcSEcCtD
Vemurafenib—Diarrhoea—Irbesartan—hypertension	3.48e-05	0.00024	CcSEcCtD
Vemurafenib—Hypotension—Lisinopril—hypertension	3.48e-05	0.00024	CcSEcCtD
Vemurafenib—Dizziness—Captopril—hypertension	3.47e-05	0.00024	CcSEcCtD
Vemurafenib—Pruritus—Betaxolol—hypertension	3.47e-05	0.00024	CcSEcCtD
Vemurafenib—Rash—Trandolapril—hypertension	3.47e-05	0.000239	CcSEcCtD
Vemurafenib—Dermatitis—Trandolapril—hypertension	3.46e-05	0.000239	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Timolol—hypertension	3.46e-05	0.000239	CcSEcCtD
Vemurafenib—Fatigue—Timolol—hypertension	3.46e-05	0.000238	CcSEcCtD
Vemurafenib—Rash—Enalapril—hypertension	3.45e-05	0.000238	CcSEcCtD
Vemurafenib—Dermatitis—Enalapril—hypertension	3.45e-05	0.000238	CcSEcCtD
Vemurafenib—Diarrhoea—Hydrochlorothiazide—hypertension	3.45e-05	0.000238	CcSEcCtD
Vemurafenib—Headache—Trandolapril—hypertension	3.44e-05	0.000238	CcSEcCtD
Vemurafenib—Vomiting—Telmisartan—hypertension	3.43e-05	0.000237	CcSEcCtD
Vemurafenib—Asthenia—Losartan—hypertension	3.43e-05	0.000237	CcSEcCtD
Vemurafenib—Headache—Enalapril—hypertension	3.43e-05	0.000237	CcSEcCtD
Vemurafenib—Rash—Telmisartan—hypertension	3.41e-05	0.000235	CcSEcCtD
Vemurafenib—Dermatitis—Telmisartan—hypertension	3.4e-05	0.000235	CcSEcCtD
Vemurafenib—Diarrhoea—Furosemide—hypertension	3.39e-05	0.000234	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Lisinopril—hypertension	3.39e-05	0.000234	CcSEcCtD
Vemurafenib—Pruritus—Losartan—hypertension	3.38e-05	0.000233	CcSEcCtD
Vemurafenib—Headache—Telmisartan—hypertension	3.38e-05	0.000233	CcSEcCtD
Vemurafenib—Dizziness—Perindopril—hypertension	3.37e-05	0.000233	CcSEcCtD
Vemurafenib—Dizziness—Irbesartan—hypertension	3.36e-05	0.000232	CcSEcCtD
Vemurafenib—Diarrhoea—Betaxolol—hypertension	3.36e-05	0.000232	CcSEcCtD
Vemurafenib—Nausea—Clonidine—hypertension	3.35e-05	0.000231	CcSEcCtD
Vemurafenib—Vomiting—Captopril—hypertension	3.34e-05	0.00023	CcSEcCtD
Vemurafenib—Dizziness—Hydrochlorothiazide—hypertension	3.33e-05	0.00023	CcSEcCtD
Vemurafenib—Rash—Captopril—hypertension	3.31e-05	0.000228	CcSEcCtD
Vemurafenib—Dermatitis—Captopril—hypertension	3.31e-05	0.000228	CcSEcCtD
Vemurafenib—Headache—Captopril—hypertension	3.29e-05	0.000227	CcSEcCtD
Vemurafenib—Dizziness—Furosemide—hypertension	3.28e-05	0.000226	CcSEcCtD
Vemurafenib—Diarrhoea—Losartan—hypertension	3.27e-05	0.000226	CcSEcCtD
Vemurafenib—Nausea—Trandolapril—hypertension	3.27e-05	0.000225	CcSEcCtD
Vemurafenib—Nausea—Enalapril—hypertension	3.25e-05	0.000224	CcSEcCtD
Vemurafenib—Dizziness—Betaxolol—hypertension	3.25e-05	0.000224	CcSEcCtD
Vemurafenib—Vomiting—Perindopril—hypertension	3.24e-05	0.000224	CcSEcCtD
Vemurafenib—Body temperature increased—Ramipril—hypertension	3.24e-05	0.000224	CcSEcCtD
Vemurafenib—Decreased appetite—Lisinopril—hypertension	3.23e-05	0.000223	CcSEcCtD
Vemurafenib—Vomiting—Irbesartan—hypertension	3.23e-05	0.000223	CcSEcCtD
Vemurafenib—Rash—Perindopril—hypertension	3.22e-05	0.000222	CcSEcCtD
Vemurafenib—Dermatitis—Perindopril—hypertension	3.21e-05	0.000222	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Lisinopril—hypertension	3.21e-05	0.000221	CcSEcCtD
Vemurafenib—Nausea—Telmisartan—hypertension	3.21e-05	0.000221	CcSEcCtD
Vemurafenib—Fatigue—Lisinopril—hypertension	3.21e-05	0.000221	CcSEcCtD
Vemurafenib—Vomiting—Hydrochlorothiazide—hypertension	3.21e-05	0.000221	CcSEcCtD
Vemurafenib—Rash—Irbesartan—hypertension	3.2e-05	0.000221	CcSEcCtD
Vemurafenib—Dermatitis—Irbesartan—hypertension	3.2e-05	0.000221	CcSEcCtD
Vemurafenib—Headache—Perindopril—hypertension	3.19e-05	0.00022	CcSEcCtD
Vemurafenib—Headache—Irbesartan—hypertension	3.18e-05	0.00022	CcSEcCtD
Vemurafenib—Constipation—Lisinopril—hypertension	3.18e-05	0.000219	CcSEcCtD
Vemurafenib—Rash—Hydrochlorothiazide—hypertension	3.18e-05	0.000219	CcSEcCtD
Vemurafenib—Dermatitis—Hydrochlorothiazide—hypertension	3.18e-05	0.000219	CcSEcCtD
Vemurafenib—Body temperature increased—Timolol—hypertension	3.17e-05	0.000219	CcSEcCtD
Vemurafenib—Dizziness—Losartan—hypertension	3.16e-05	0.000218	CcSEcCtD
Vemurafenib—Headache—Hydrochlorothiazide—hypertension	3.16e-05	0.000218	CcSEcCtD
Vemurafenib—Vomiting—Furosemide—hypertension	3.15e-05	0.000217	CcSEcCtD
Vemurafenib—Rash—Furosemide—hypertension	3.13e-05	0.000216	CcSEcCtD
Vemurafenib—Dermatitis—Furosemide—hypertension	3.12e-05	0.000215	CcSEcCtD
Vemurafenib—Vomiting—Betaxolol—hypertension	3.12e-05	0.000215	CcSEcCtD
Vemurafenib—Nausea—Captopril—hypertension	3.12e-05	0.000215	CcSEcCtD
Vemurafenib—Headache—Furosemide—hypertension	3.11e-05	0.000214	CcSEcCtD
Vemurafenib—Rash—Betaxolol—hypertension	3.09e-05	0.000213	CcSEcCtD
Vemurafenib—Dermatitis—Betaxolol—hypertension	3.09e-05	0.000213	CcSEcCtD
Vemurafenib—Headache—Betaxolol—hypertension	3.07e-05	0.000212	CcSEcCtD
Vemurafenib—Vomiting—Losartan—hypertension	3.04e-05	0.00021	CcSEcCtD
Vemurafenib—Nausea—Perindopril—hypertension	3.03e-05	0.000209	CcSEcCtD
Vemurafenib—Hypersensitivity—Ramipril—hypertension	3.02e-05	0.000208	CcSEcCtD
Vemurafenib—Nausea—Irbesartan—hypertension	3.02e-05	0.000208	CcSEcCtD
Vemurafenib—Rash—Losartan—hypertension	3.02e-05	0.000208	CcSEcCtD
Vemurafenib—Dermatitis—Losartan—hypertension	3.01e-05	0.000208	CcSEcCtD
Vemurafenib—Headache—Losartan—hypertension	3e-05	0.000207	CcSEcCtD
Vemurafenib—Nausea—Hydrochlorothiazide—hypertension	2.99e-05	0.000207	CcSEcCtD
Vemurafenib—Hypersensitivity—Timolol—hypertension	2.95e-05	0.000204	CcSEcCtD
Vemurafenib—Nausea—Furosemide—hypertension	2.94e-05	0.000203	CcSEcCtD
Vemurafenib—Asthenia—Ramipril—hypertension	2.94e-05	0.000203	CcSEcCtD
Vemurafenib—Body temperature increased—Lisinopril—hypertension	2.94e-05	0.000203	CcSEcCtD
Vemurafenib—Nausea—Betaxolol—hypertension	2.92e-05	0.000201	CcSEcCtD
Vemurafenib—Pruritus—Ramipril—hypertension	2.9e-05	0.0002	CcSEcCtD
Vemurafenib—Asthenia—Timolol—hypertension	2.88e-05	0.000198	CcSEcCtD
Vemurafenib—Nausea—Losartan—hypertension	2.84e-05	0.000196	CcSEcCtD
Vemurafenib—Pruritus—Timolol—hypertension	2.84e-05	0.000196	CcSEcCtD
Vemurafenib—Diarrhoea—Ramipril—hypertension	2.81e-05	0.000194	CcSEcCtD
Vemurafenib—Diarrhoea—Timolol—hypertension	2.74e-05	0.000189	CcSEcCtD
Vemurafenib—Hypersensitivity—Lisinopril—hypertension	2.74e-05	0.000189	CcSEcCtD
Vemurafenib—Dizziness—Ramipril—hypertension	2.71e-05	0.000187	CcSEcCtD
Vemurafenib—Asthenia—Lisinopril—hypertension	2.67e-05	0.000184	CcSEcCtD
Vemurafenib—Dizziness—Timolol—hypertension	2.65e-05	0.000183	CcSEcCtD
Vemurafenib—Pruritus—Lisinopril—hypertension	2.63e-05	0.000182	CcSEcCtD
Vemurafenib—Vomiting—Ramipril—hypertension	2.61e-05	0.00018	CcSEcCtD
Vemurafenib—Rash—Ramipril—hypertension	2.59e-05	0.000178	CcSEcCtD
Vemurafenib—Dermatitis—Ramipril—hypertension	2.58e-05	0.000178	CcSEcCtD
Vemurafenib—Headache—Ramipril—hypertension	2.57e-05	0.000177	CcSEcCtD
Vemurafenib—Vomiting—Timolol—hypertension	2.55e-05	0.000176	CcSEcCtD
Vemurafenib—Diarrhoea—Lisinopril—hypertension	2.54e-05	0.000176	CcSEcCtD
Vemurafenib—Rash—Timolol—hypertension	2.53e-05	0.000174	CcSEcCtD
Vemurafenib—Dermatitis—Timolol—hypertension	2.53e-05	0.000174	CcSEcCtD
Vemurafenib—Headache—Timolol—hypertension	2.51e-05	0.000173	CcSEcCtD
Vemurafenib—Dizziness—Lisinopril—hypertension	2.46e-05	0.00017	CcSEcCtD
Vemurafenib—Nausea—Ramipril—hypertension	2.44e-05	0.000168	CcSEcCtD
Vemurafenib—Nausea—Timolol—hypertension	2.38e-05	0.000164	CcSEcCtD
Vemurafenib—Vomiting—Lisinopril—hypertension	2.36e-05	0.000163	CcSEcCtD
Vemurafenib—Rash—Lisinopril—hypertension	2.35e-05	0.000162	CcSEcCtD
Vemurafenib—Dermatitis—Lisinopril—hypertension	2.34e-05	0.000162	CcSEcCtD
Vemurafenib—Headache—Lisinopril—hypertension	2.33e-05	0.000161	CcSEcCtD
Vemurafenib—Nausea—Lisinopril—hypertension	2.21e-05	0.000152	CcSEcCtD
Vemurafenib—RAF1—Disease—PTEN—hypertension	1.9e-06	1.73e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GCLC—hypertension	1.89e-06	1.72e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CETP—hypertension	1.89e-06	1.72e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CDKN1A—hypertension	1.89e-06	1.72e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—PTEN—hypertension	1.89e-06	1.71e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—MAPK8—hypertension	1.89e-06	1.71e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GNB3—hypertension	1.88e-06	1.71e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PPARGC1A—hypertension	1.88e-06	1.71e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCL2—hypertension	1.88e-06	1.7e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—HMOX1—hypertension	1.87e-06	1.7e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—TH—hypertension	1.85e-06	1.68e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CAT—hypertension	1.85e-06	1.68e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CALM2—hypertension	1.85e-06	1.68e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IGF1—hypertension	1.84e-06	1.67e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—AKT2—hypertension	1.84e-06	1.67e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—EP300—hypertension	1.84e-06	1.67e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—EP300—hypertension	1.84e-06	1.67e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—EGFR—hypertension	1.83e-06	1.67e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GNAS—hypertension	1.83e-06	1.66e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—LRP2—hypertension	1.83e-06	1.66e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CYP2C18—hypertension	1.83e-06	1.66e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ALB—hypertension	1.82e-06	1.65e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—EP300—hypertension	1.82e-06	1.65e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CYP17A1—hypertension	1.81e-06	1.65e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PTGS2—hypertension	1.81e-06	1.64e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GCG—hypertension	1.8e-06	1.64e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—SLC2A4—hypertension	1.8e-06	1.64e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—EP300—hypertension	1.8e-06	1.63e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PTGS1—hypertension	1.8e-06	1.63e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ENO1—hypertension	1.8e-06	1.63e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—APOB—hypertension	1.79e-06	1.63e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—SRC—hypertension	1.79e-06	1.62e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hypertension	1.77e-06	1.6e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—SRC—hypertension	1.77e-06	1.6e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—HSPG2—hypertension	1.76e-06	1.6e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—TGFB1—hypertension	1.76e-06	1.59e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—SERPINE1—hypertension	1.75e-06	1.59e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—SRC—hypertension	1.75e-06	1.59e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GOT1—hypertension	1.75e-06	1.58e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GSTM1—hypertension	1.75e-06	1.58e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PIK3R1—hypertension	1.74e-06	1.58e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—NOS3—hypertension	1.74e-06	1.58e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—VEGFA—hypertension	1.74e-06	1.58e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CTGF—hypertension	1.73e-06	1.57e-05	CbGpPWpGaD
Vemurafenib—BRAF—Disease—IL6—hypertension	1.72e-06	1.56e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—HMGCR—hypertension	1.71e-06	1.56e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GOT2—hypertension	1.71e-06	1.56e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—LPL—hypertension	1.71e-06	1.56e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GLP1R—hypertension	1.7e-06	1.54e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ALOX5—hypertension	1.7e-06	1.54e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—STK11—hypertension	1.7e-06	1.54e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CYP19A1—hypertension	1.7e-06	1.54e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—FGF2—hypertension	1.7e-06	1.54e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hypertension	1.69e-06	1.53e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—RHOA—hypertension	1.69e-06	1.53e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ADCY5—hypertension	1.68e-06	1.52e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ADRA2A—hypertension	1.68e-06	1.52e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—EGFR—hypertension	1.68e-06	1.52e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GPX1—hypertension	1.67e-06	1.52e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PIK3R1—hypertension	1.67e-06	1.52e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—NOS3—hypertension	1.67e-06	1.52e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PRKCA—hypertension	1.65e-06	1.5e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CYP1A1—hypertension	1.65e-06	1.5e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CD36—hypertension	1.63e-06	1.48e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—MYC—hypertension	1.6e-06	1.45e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TGFB1—hypertension	1.6e-06	1.45e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PTGS2—hypertension	1.6e-06	1.45e-05	CbGpPWpGaD
Vemurafenib—BRAF—Disease—AKT1—hypertension	1.59e-06	1.44e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—MYC—hypertension	1.58e-06	1.44e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PTEN—hypertension	1.58e-06	1.43e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—TGFB1—hypertension	1.58e-06	1.43e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—COMT—hypertension	1.58e-06	1.43e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—RELA—hypertension	1.57e-06	1.43e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—TH—hypertension	1.57e-06	1.42e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—MYC—hypertension	1.57e-06	1.42e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—EGFR—hypertension	1.57e-06	1.42e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—TGFB1—hypertension	1.56e-06	1.42e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CALM2—hypertension	1.56e-06	1.42e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ALDH2—hypertension	1.56e-06	1.41e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GNB3—hypertension	1.55e-06	1.41e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PPARGC1A—hypertension	1.55e-06	1.41e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—EGFR—hypertension	1.55e-06	1.4e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—HMOX1—hypertension	1.55e-06	1.4e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—hypertension	1.55e-06	1.4e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MTOR—hypertension	1.54e-06	1.4e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—MTHFR—hypertension	1.54e-06	1.4e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—EGFR—hypertension	1.53e-06	1.39e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—SLC2A4—hypertension	1.53e-06	1.39e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GCG—hypertension	1.53e-06	1.39e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CAT—hypertension	1.53e-06	1.39e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—HBA1—hypertension	1.52e-06	1.38e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PPARA—hypertension	1.51e-06	1.37e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GNAS—hypertension	1.51e-06	1.37e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—EP300—hypertension	1.51e-06	1.37e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CYP11A1—hypertension	1.51e-06	1.37e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CXCL8—hypertension	1.48e-06	1.35e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—APOB—hypertension	1.48e-06	1.34e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—SLC9A1—hypertension	1.48e-06	1.34e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GSTT1—hypertension	1.48e-06	1.34e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GOT1—hypertension	1.48e-06	1.34e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—AGT—hypertension	1.47e-06	1.33e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GCLC—hypertension	1.46e-06	1.33e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CETP—hypertension	1.46e-06	1.33e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—TP53—hypertension	1.44e-06	1.31e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CALM1—hypertension	1.44e-06	1.31e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GSTM1—hypertension	1.44e-06	1.31e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—APOE—hypertension	1.44e-06	1.3e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—STK11—hypertension	1.44e-06	1.3e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CYP19A1—hypertension	1.44e-06	1.3e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CAV1—hypertension	1.42e-06	1.29e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—APOA1—hypertension	1.42e-06	1.29e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—LPL—hypertension	1.41e-06	1.28e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—IL6—hypertension	1.41e-06	1.28e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CYP17A1—hypertension	1.4e-06	1.27e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PTEN—hypertension	1.39e-06	1.26e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ENO1—hypertension	1.39e-06	1.26e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PTGS1—hypertension	1.39e-06	1.26e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ADCY5—hypertension	1.39e-06	1.26e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GPX1—hypertension	1.38e-06	1.25e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PRKCA—hypertension	1.37e-06	1.24e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CYP1A1—hypertension	1.37e-06	1.24e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hypertension	1.35e-06	1.22e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CD36—hypertension	1.34e-06	1.22e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MMP9—hypertension	1.34e-06	1.22e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CDKN1A—hypertension	1.34e-06	1.21e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—COMT—hypertension	1.34e-06	1.21e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CTGF—hypertension	1.33e-06	1.21e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PTEN—hypertension	1.33e-06	1.21e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—EP300—hypertension	1.33e-06	1.2e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—HMGCR—hypertension	1.32e-06	1.2e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GOT2—hypertension	1.32e-06	1.2e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GNB3—hypertension	1.32e-06	1.19e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PPARGC1A—hypertension	1.32e-06	1.19e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TP53—hypertension	1.32e-06	1.19e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—HMOX1—hypertension	1.31e-06	1.19e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MAPK8—hypertension	1.3e-06	1.18e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—AKT1—hypertension	1.3e-06	1.18e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ADRA2A—hypertension	1.29e-06	1.17e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CAT—hypertension	1.29e-06	1.17e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL6—hypertension	1.29e-06	1.17e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hypertension	1.29e-06	1.17e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GNAS—hypertension	1.28e-06	1.16e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—MTHFR—hypertension	1.27e-06	1.16e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—EP300—hypertension	1.27e-06	1.15e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—APOB—hypertension	1.26e-06	1.14e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PPARG—hypertension	1.25e-06	1.14e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PPARA—hypertension	1.25e-06	1.13e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—SRC—hypertension	1.24e-06	1.12e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—POMC—hypertension	1.23e-06	1.12e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—INS—hypertension	1.23e-06	1.11e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GSTM1—hypertension	1.22e-06	1.11e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—AKT1—hypertension	1.22e-06	1.11e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—TH—hypertension	1.21e-06	1.1e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—AGT—hypertension	1.21e-06	1.1e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CALM2—hypertension	1.21e-06	1.1e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—VEGFA—hypertension	1.2e-06	1.09e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IL6—hypertension	1.2e-06	1.09e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—LPL—hypertension	1.2e-06	1.09e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CALM1—hypertension	1.19e-06	1.08e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—IL6—hypertension	1.19e-06	1.08e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—AKT1—hypertension	1.19e-06	1.08e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—APOE—hypertension	1.19e-06	1.08e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—IL6—hypertension	1.18e-06	1.07e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—SLC2A4—hypertension	1.18e-06	1.07e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GCG—hypertension	1.18e-06	1.07e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CAV1—hypertension	1.18e-06	1.07e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ADCY5—hypertension	1.17e-06	1.06e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—APOA1—hypertension	1.17e-06	1.06e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GPX1—hypertension	1.17e-06	1.06e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CYP1A1—hypertension	1.16e-06	1.05e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PRKCA—hypertension	1.16e-06	1.05e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GOT1—hypertension	1.14e-06	1.04e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CD36—hypertension	1.14e-06	1.03e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—AKT1—hypertension	1.11e-06	1.01e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CYP19A1—hypertension	1.11e-06	1.01e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—STK11—hypertension	1.11e-06	1.01e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MYC—hypertension	1.11e-06	1.01e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TGFB1—hypertension	1.11e-06	1e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—AKT1—hypertension	1.1e-06	9.96e-06	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—AKT1—hypertension	1.09e-06	9.87e-06	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—EGFR—hypertension	1.08e-06	9.84e-06	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—MTHFR—hypertension	1.08e-06	9.79e-06	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—NOS3—hypertension	1.08e-06	9.77e-06	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PIK3R1—hypertension	1.08e-06	9.77e-06	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PPARA—hypertension	1.06e-06	9.61e-06	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PPARG—hypertension	1.03e-06	9.37e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—COMT—hypertension	1.03e-06	9.35e-06	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—AGT—hypertension	1.03e-06	9.3e-06	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—POMC—hypertension	1.02e-06	9.25e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PPARGC1A—hypertension	1.02e-06	9.22e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GNB3—hypertension	1.02e-06	9.22e-06	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—INS—hypertension	1.01e-06	9.19e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—HMOX1—hypertension	1.01e-06	9.18e-06	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CALM1—hypertension	1.01e-06	9.15e-06	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—APOE—hypertension	1e-06	9.12e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CAT—hypertension	9.98e-07	9.06e-06	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CAV1—hypertension	9.95e-07	9.03e-06	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—APOA1—hypertension	9.93e-07	9.01e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GNAS—hypertension	9.89e-07	8.98e-06	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PTGS2—hypertension	9.84e-07	8.93e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—APOB—hypertension	9.69e-07	8.79e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GSTM1—hypertension	9.42e-07	8.55e-06	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ALB—hypertension	9.29e-07	8.43e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—LPL—hypertension	9.25e-07	8.39e-06	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—AKT1—hypertension	9.11e-07	8.27e-06	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TP53—hypertension	9.1e-07	8.26e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ADCY5—hypertension	9.06e-07	8.22e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GPX1—hypertension	9.02e-07	8.19e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CYP1A1—hypertension	8.93e-07	8.11e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PRKCA—hypertension	8.93e-07	8.11e-06	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PIK3R1—hypertension	8.88e-07	8.06e-06	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—NOS3—hypertension	8.88e-07	8.06e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CD36—hypertension	8.79e-07	7.98e-06	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PPARG—hypertension	8.75e-07	7.94e-06	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—POMC—hypertension	8.63e-07	7.83e-06	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PTEN—hypertension	8.58e-07	7.79e-06	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—INS—hypertension	8.58e-07	7.79e-06	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IL6—hypertension	8.33e-07	7.56e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—MTHFR—hypertension	8.33e-07	7.56e-06	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—EP300—hypertension	8.19e-07	7.43e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PPARA—hypertension	8.17e-07	7.41e-06	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PTGS2—hypertension	8.13e-07	7.37e-06	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—AKT1—hypertension	8.02e-07	7.27e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—AGT—hypertension	7.91e-07	7.18e-06	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ALB—hypertension	7.87e-07	7.14e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CALM1—hypertension	7.78e-07	7.06e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—APOE—hypertension	7.75e-07	7.04e-06	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—AKT1—hypertension	7.68e-07	6.97e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CAV1—hypertension	7.68e-07	6.97e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—APOA1—hypertension	7.66e-07	6.96e-06	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—NOS3—hypertension	7.53e-07	6.83e-06	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PIK3R1—hypertension	7.53e-07	6.83e-06	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PTEN—hypertension	7.09e-07	6.43e-06	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PTGS2—hypertension	6.88e-07	6.25e-06	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—EP300—hypertension	6.76e-07	6.13e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PPARG—hypertension	6.75e-07	6.13e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—POMC—hypertension	6.66e-07	6.04e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—INS—hypertension	6.62e-07	6.01e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ALB—hypertension	6.07e-07	5.51e-06	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PTEN—hypertension	6e-07	5.45e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PIK3R1—hypertension	5.81e-07	5.27e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—NOS3—hypertension	5.81e-07	5.27e-06	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—EP300—hypertension	5.73e-07	5.2e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PTGS2—hypertension	5.31e-07	4.82e-06	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—AKT1—hypertension	4.95e-07	4.49e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PTEN—hypertension	4.63e-07	4.2e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—EP300—hypertension	4.42e-07	4.01e-06	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—AKT1—hypertension	4.08e-07	3.71e-06	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—AKT1—hypertension	3.46e-07	3.14e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—AKT1—hypertension	2.67e-07	2.42e-06	CbGpPWpGaD
